8-K: CIMG Faces Nasdaq Delisting Threat Over Late 10-Q Filing

CIMG Inc. received an additional delisting notice from Nasdaq due to its failure to timely file its Quarterly Report on Form 10-Q for the period ended December 31, 2025.

Summary

• CIMG Inc. received a letter from Nasdaq on February 23, 2026, indicating that the Nasdaq Hearings Panel will consider the company's non-compliance with Listing Rule 5250(c)(1).
• The non-compliance stems from the company's failure to timely file its Quarterly Report on Form 10-Q for the period ended December 31, 2025.
• This failure constitutes an additional basis for the potential delisting of CIMG's securities from The Nasdaq Capital Market.
• The company is already under a Mandatory Panel Monitor, imposed on December 4, 2025, which remains in effect until November 14, 2026.
• Failure to maintain compliance during this monitor period would result in a delisting determination.
• The Nasdaq letter does not immediately affect the listing or trading of CIMG's common stock.
• CIMG is working diligently to complete and file the Form 10-Q as soon as practicable.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a highly negative development, indicating severe regulatory non-compliance and a significant risk of delisting, which could severely impact shareholder value.

Positives

• The Nasdaq letter does not immediately impact the listing or trading of CIMG's common stock on The Nasdaq Capital Market.
• Management states they are working diligently to complete and file the Form 10-Q as soon as practicable.

Negatives

• CIMG Inc. received an additional delisting determination letter from Nasdaq on February 23, 2026.
• The company failed to timely file its Quarterly Report on Form 10-Q for the period ended December 31, 2025, violating Nasdaq Listing Rule 5250(c)(1).
• This non-compliance serves as an additional basis for potential delisting from The Nasdaq Capital Market.
• CIMG is already subject to a Mandatory Panel Monitor, imposed on December 4, 2025, which mandates delisting if compliance is not maintained by November 14, 2026.

Risks

• The company may not regain or maintain compliance with Nasdaq listing requirements.
• The Nasdaq Hearings Panel may determine to delist CIMG's securities.
• Risks related to the completion and timing of the company's financial reporting and audit process.
• General risks described in the company's filings with the Securities and Exchange Commission.

Future Outlook

CIMG Inc. plans to work diligently to complete and file its Form 10-Q as soon as practicable to address the non-compliance and aims to regain and maintain compliance with Nasdaq listing requirements. However, there is a risk that the company may not succeed in these efforts, potentially leading to delisting.

Management Comments

• The Company is working diligently to complete and file the Form 10-Q as soon as practicable.

Industry Context

StockSavvy.ai notes that timely and accurate financial reporting is a fundamental requirement for publicly traded companies, especially those listed on major exchanges like Nasdaq. Non-compliance, particularly repeated instances or those leading to delisting notices, often signals underlying operational or governance issues. For a company like CIMG, which describes itself as specializing in digital health and sales development with a cryptocurrency focus, maintaining investor confidence through robust financial transparency is crucial, particularly given the volatile nature of the crypto market and the scrutiny often applied to companies in this sector.

Comparison to Industry Standards

• Timely filing of quarterly reports (Form 10-Q) is a standard regulatory requirement for all publicly traded companies on Nasdaq, including peers in the digital health and technology sectors.
• Failure to meet this standard, as seen with CIMG, places the company significantly below industry best practices for financial transparency and regulatory compliance.
• Companies like Teladoc Health (TDOC) or Amwell (AMWL) in the digital health space consistently meet their filing deadlines, setting a benchmark for operational efficiency and governance that CIMG is currently failing to achieve.
• The imposition of a Mandatory Panel Monitor and an additional delisting basis indicates a severe deviation from the expected compliance levels for a Nasdaq-listed entity.

Stakeholder Impact

• Shareholders: Face significant risk of delisting, which could lead to a substantial decrease in share price, reduced liquidity, and potential loss of investment.
• Employees: Potential uncertainty regarding the company's future and stability if delisting occurs.
• Customers/Business Partners: May experience reduced confidence in the company's stability and operational integrity, potentially impacting business relationships.
• Regulatory Authorities: Nasdaq and SEC are actively monitoring the company's compliance, indicating heightened scrutiny.

Next Steps

• CIMG Inc. must complete and file its Quarterly Report on Form 10-Q for the period ended December 31, 2025, as soon as practicable.
• The company needs to address the Nasdaq Hearings Panel regarding its non-compliance.
• CIMG must maintain compliance with Nasdaq listing rules throughout the Mandatory Panel Monitor period, which ends on November 14, 2026.

Key Dates

Recommendation

The company faces an imminent and severe risk of delisting from Nasdaq due to repeated and ongoing non-compliance with fundamental listing rules, specifically the failure to timely file its quarterly report. This situation, compounded by an existing Mandatory Panel Monitor, signals significant governance and operational deficiencies. Delisting would severely impair liquidity and likely lead to a substantial loss of shareholder value, making a strong sell recommendation appropriate for investors seeking to mitigate further downside risk.

Keywords

CIMG Inc., Nasdaq, delisting, Form 10-Q, late filing, compliance, financial reporting, digital health, sales development, cryptocurrency, IMG